Your browser doesn't support javascript.
loading
Analysis of CD8+ TCRß Chain repertoire in peripheral blood of vitiligo via high-throughput sequencing.
Xiong, Hao; Ji, Liyan; Yang, Jin; Wan, Jianji; Song, Mengmeng; Liu, Guangren; Yang, Ling; Dong, Xiuqin.
Afiliação
  • Xiong H; Department of Dermatology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, China.
  • Ji L; Beijing GenePlus Genomics Institute, China.
  • Yang J; Department of Allergy and Immunology, Huashan Hospital, Fudan University, Shanghai, China; Department of Dermatology, Huashan Hospital, Fudan University, Shanghai, China.
  • Wan J; Department of Dermatology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, China.
  • Song M; Beijing GenePlus Genomics Institute, China.
  • Liu G; Department of Dermatology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, China.
  • Yang L; Beijing GenePlus Genomics Institute, China.
  • Dong X; Department of Dermatology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, China. Electronic address: dongxiuqin@gdph.org.cn.
Mol Immunol ; 160: 112-120, 2023 08.
Article em En | MEDLINE | ID: mdl-37421821
ABSTRACT
Vitiligo is an autoimmune depigmentation dermatosis induced by melanocyte destruction, and CD8+ T cells play a pivotal role in melanocyte destruction. However, an accurate profile of the CD8+ T cell receptor (TCR) repertoire in vitiligo patients has not been reported, and the clonotype features of the involved CD8+ T cells remain largely unknown. This study aimed to assess the TCRß chain repertoire diversity and composition of blood in nine nonsegmental vitiligo patients via high-throughput sequencing. Vitiligo patients manifested a low TCRß repertoire diversity with highly expanded clones. Differential usage of TRBV, the TRBJ gene, and the TRBV/TRBJ combination were compared between patients with vitiligo and healthy controls. A set of TRBV/TRBJ combinations could differentiate patients with vitiligo from healthy controls (area under the curve = 0.9383, 95% CI 0.8167-1.00). Our study revealed distinct TCRß repertoires of CD8+ T cells in patients with vitiligo and will help explore novel immune biomarkers and potential therapeutic targets for vitiligo.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Autoimunes / Vitiligo Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Mol Immunol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Autoimunes / Vitiligo Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Mol Immunol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China